DK
Reklame
Epidemiologist - Real World Evidence, Søborg
Free
Epidemiologist - Real World Evidence, Søborg
Denmark, Denmark, Søborg,
Udgivet November 21, 2023
Beskrivelse
The job is globally oriented and excellent communication skills together with interest in co-operating with stakeholders across the globe is a must. About the department In Development, we are responsible for managing clinical drug development worldwide from early development phases to product launch and beyond. We provide medical and scientific documentation for clinical submissions and authorities while ensuring that the process lives up to global standards, regulations, and business ethics. The department of Real-World Science is part of Data Science in Development and located in Søborg, Denmark. The department focus on insights and causal relationships from real world data (RWD) through advanced statistical methods. We analyse many different data sources to generate evidence to support clinical drug development projects and launched products. You will be joining a team of highly professional, engaged, and motivated data scientists and epidemiologists. Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing, and sales – we’re all working to move the needle on patient care.
Joboplysninger
|
⇐ Tidligere arbejde |
Næste job ⇒ |
Kontakt arbejdsgiver
Arbejdsgiver info
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 49,300 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com.
This page isn't intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk's office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industries. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here http://www.novonordisk.com/communityguidelines
